Scientists have identified a new gene structure that’s a key component in brain development, potentially helping people who have severe cerebral palsy learn to read and write.
The findings, published in Nature Medicine, could lead to new ways to treat people with cerebral palsys, or some forms of the disease, by creating new genetic materials.
The team’s discovery, led by Dr. Richard Wiesner, an associate professor of biological sciences at the University of Wisconsin-Madison, and graduate student Joshua G. McBride, found the genes that make up a protein that plays a role in the production of the protein brain-derived neurotrophic factor.
The new gene is one of several proteins found in the brain that have previously been linked to development and development disorders, such as autism and Alzheimer’s.
Researchers had previously found a gene in humans with the condition that helped the body to produce the protein, but this gene wasn’t expressed in the same way in mice.
The scientists found that in mice, the protein that the mouse has is more likely to be expressed in neurons in the mouse’s brains.
The researchers found the gene is more specific in humans.
In humans, the gene’s expression can be increased in areas of the brain involved in learning and memory, including the hippocampus, the part of the hippocampus that is critical for learning.
Scientists said they hope to develop drugs that target the protein and use it to treat a wide range of brain disorders, including autism, epilepsy, attention deficit hyperactivity disorder and Parkinson’s disease.
“The brain is a complicated machine, and it is still in the early stages of development,” McBride said.
“We are trying to understand how the different stages of life in humans develop differently.”
McBride said the gene could be used to identify a specific set of genes that might help with specific brain disorders.
For example, the researchers found that the protein could be targeted to certain regions of the human brain, including those involved in memory, learning and attention.
“There are lots of different genes that have been implicated in some brain disorders and they are all expressed differently in different parts of the brains,” McQueen said.
“We know that one gene is involved in different areas of learning, memory and attention, and we know that another gene is associated with different kinds of cognitive disorders.”
For example:People with a severe form of cerebral palsying often have problems reading and writing, and have trouble with some aspects of their day-to-day life.
Researchers say the finding could lead them to identify genes that are more likely for those brain disorders to develop.
For instance, if researchers find that a particular gene is particularly active in certain brain regions, it could be a way to improve the brain’s ability to regulate its own functions.
McBride and Wiesning have already developed drugs that block the protein in the human genome.
In addition, the team has also shown that inhibiting the gene can lead to the development of a drug that blocks it in mice and humans.
“If we can find a gene that is specifically involved in some of these disorders, we could probably target it and make a drug,” Mc Bride said.
McQueen said he is also exploring the possibility of using the protein to treat brain tumors.
In addition to McBride and McBride’s research, Wiesners team also is collaborating with researchers from UC Berkeley, Johns Hopkins University, the University at Albany, the U.S. National Institutes of Health and the University Hospitals of Vienna.
The study was supported by grants from the National Institutes, U.s.
Department of Energy, and the Department of Defense.